1. Home
  2. IDXX vs ALC Comparison

IDXX vs ALC Comparison

Compare IDXX & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEXX Laboratories Inc.

IDXX

IDEXX Laboratories Inc.

HOLD

Current Price

$569.55

Market Cap

57.1B

Sector

Health Care

ML Signal

HOLD

Logo Alcon Inc.

ALC

Alcon Inc.

HOLD

Current Price

$74.56

Market Cap

35.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDXX
ALC
Founded
1983
1945
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.1B
35.9B
IPO Year
1996
2002

Fundamental Metrics

Financial Performance
Metric
IDXX
ALC
Price
$569.55
$74.56
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$712.22
$89.38
AVG Volume (30 Days)
446.7K
1.3M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
0.29%
EPS Growth
22.59
N/A
EPS
13.08
N/A
Revenue
$4,303,702,000.00
N/A
Revenue This Year
$10.88
$8.01
Revenue Next Year
$8.59
$6.43
P/E Ratio
$43.61
$38.31
Revenue Growth
10.42
N/A
52 Week Low
$356.25
$71.55
52 Week High
$769.98
$99.20

Technical Indicators

Market Signals
Indicator
IDXX
ALC
Relative Strength Index (RSI) 38.56 38.96
Support Level $567.62 $72.49
Resistance Level $657.26 $76.99
Average True Range (ATR) 15.26 1.54
MACD 1.21 -0.00
Stochastic Oscillator 40.88 25.58

Price Performance

Historical Comparison
IDXX
ALC

About IDXX IDEXX Laboratories Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: